qz
14h ago
10°
Head of Kraken Institutional talks benefits of integrating with ICE Chat
Head of Kraken Institutional talks benefits of integrating with ICE Chat
Hotnews ⁄ 3
qz
qz
15h ago
9°
Centrus CEO Amir Vexler says it created 'historic' moment in U.S.
Centrus CEO Amir Vexler says it created 'historic' moment in U.S.
qz
47h ago
9°
VENU CEO J.W. Roth on how latest raise will fuel company’s expansion efforts
VENU CEO J.W.
qz
39h ago
8°
CodePath CEO Michael Ellison on what survey shows about tech hiring trends
CodePath CEO Michael Ellison on what survey shows about tech hiring trends
qz
13h ago
8°
Trump's attacks on Fed Chair Jerome Powell are backfiring
Trump's assault on the Federal Reserve is stalling on multiple fronts, and could end up keeping Powell at the Fed even after his term as chair ends
qz
14h ago
8°
Oracle NetSuite founder Evan Goldberg discloses how AI is bolstering platform
Oracle NetSuite founder Evan Goldberg discloses how AI is bolstering platform
qz
38h ago
7°
Vast Data CEO Renen Hallak talks AI innovation at Vast Forward 2026
Vast Data CEO Renen Hallak talks AI innovation at Vast Forward 2026
qz
15h ago
7°
NYSE market strategist Eric Criscuolo on what investors took away from Fed decision
NYSE market strategist Eric Criscuolo on what investors took away from Fed decision
qz
38h ago
7°
Frore Systems CEO Seshu Madhavapeddy on significance of reaching unicorn status
Frore Systems CEO Seshu Madhavapeddy on significance of reaching unicorn status
qz
43h ago
7°
OpenAI is getting sued by Merriam-Webster
Merriam-Webster and Encyclopedia Britannica sued OpenAI, alleging ChatGPT was trained on nearly 100,000 of their copyrighted articles
qz
14h ago
7°
Similarweb report shows how GenAI is reshaping competitive dynamics
Similarweb report shows how GenAI is reshaping competitive dynamics
qz
15h ago
7°
Alpaca CEO Yoshi Yokokawa on firm's AI push following $150 million funding round
Alpaca CEO Yoshi Yokokawa on firm's AI push following $150 million funding round
qz
21h ago
6°
Eli Lilly's experimental diabetes drug cut weight by 17% in a study
Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals
qz
15h ago
6°
EEI CEO Drew Maloney provides energy outlook for industry after ringing bell
EEI CEO Drew Maloney provides energy outlook for industry after ringing bell
qz
14h ago
6°
Nomad CEO Lucas Vargas on helping Brazilians build wealth at Endeavor Week 2025
Nomad CEO Lucas Vargas on helping Brazilians build wealth at Endeavor Week 2025
qz
39h ago
5°
Farmer Mac CEO Brad Nordholm discusses state of U.S. agriculture
Farmer Mac CEO Brad Nordholm discusses state of U.S.